The Evolving Landscape of Psoriasis Treatment

New Treatment Paradigms in Psoriasis: Understanding and Incorporating Recent and Emerging Trends

The Evolving Landscape of Psoriasis Treatment

Mar
2018
Vol. 37. No. 2
April W Armstrong, MD, MPH | Kenneth B. Gordon, MD | M. Alan Menter, MD | Jashin J. Wu, MD
has revealed much about the multisystemic nature of the disease. Current and emerging biologic agents may reliably achieve a Psoriasis Area and Severity Index (PASI 75) up to 90. Initially, clinicians select therapies based on the severity of the psoriasis. Although mild disease can be treated with topical agents, for patients with moderate to severe disease, concurrent therapy with oral systemic agents, biologics, and/or phototherapy needs to be considered. In some instances, clinicians may need to combine me
VIEW FULL ARTICLE PDF